| Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. MC Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J ... | 1164* | 2019 |
| Ulcerative colitis–risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study MS Silverberg, JH Cho, JD Rioux, DPB McGovern, J Wu, V Annese, ... Nature genetics 41 (2), 216-220, 2009 | 511 | 2009 |
| Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease G Monteleone, MF Neurath, S Ardizzone, A Di Sabatino, MC Fantini, ... New England Journal of Medicine 372 (12), 1104-1113, 2015 | 487 | 2015 |
| Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ... Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011 | 392 | 2011 |
| Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study C Bezzio, S Saibeni, A Variola, M Allocca, A Massari, V Gerardi, V Casini, ... Gut 69 (7), 1213-1217, 2020 | 356 | 2020 |
| Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection M Regueiro, BG Feagan, B Zou, J Johanns, MA Blank, M Chevrier, ... Gastroenterology 150 (7), 1568-1578, 2016 | 346 | 2016 |
| Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis V Annese, MR Valvano, O Palmieri, A Latiano, F Bossa, A Andriulli World journal of gastroenterology: WJG 12 (23), 3636, 2006 | 184 | 2006 |
| Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between … BD Juran, GM Hirschfield, P Invernizzi, EJ Atkinson, Y Li, G Xie, R Kosoy, ... Human molecular genetics 21 (23), 5209-5221, 2012 | 180 | 2012 |
| Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection S Ben-Horin, M Margalit, P Bossuyt, J Maul, Y Shapira, D Bojic, ... Clinical Gastroenterology and Hepatology 7 (9), 981-987, 2009 | 164 | 2009 |
| The PROSIT-BIO cohort: a prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar G Fiorino, N Manetti, A Armuzzi, A Orlando, A Variola, S Bonovas, ... Inflammatory bowel diseases 23 (2), 233-243, 2017 | 155 | 2017 |
| Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study A Bourrier, F Carrat, JF Colombel, AM Bouvier, V Abitbol, P Marteau, ... Alimentary pharmacology & therapeutics 43 (2), 252-261, 2016 | 150 | 2016 |
| Methotrexate is not superior to placebo for inducing steroid-free remission, but induces steroid-free clinical remission in a larger proportion of patients with ulcerative colitis F Carbonnel, JF Colombel, J Filippi, KH Katsanos, L Peyrin-Biroulet, ... Gastroenterology 150 (2), 380-388. e4, 2016 | 145 | 2016 |
| Randomised controlled trial of mesalazine in IBS G Barbara, C Cremon, V Annese, G Basilisco, F Bazzoli, M Bellini, ... Gut 65 (1), 82-90, 2016 | 132 | 2016 |
| Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD) M Daperno, M Comberlato, F Bossa, L Biancone, AG Bonanomi, ... Digestive and Liver Disease 46 (11), 969-973, 2014 | 118 | 2014 |
| Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial F Bossa, S Fiorella, N Caruso, L Accadia, G Napolitano, MR Valvano, ... Official journal of the American College of Gastroenterology| ACG 102 (3 …, 2007 | 118 | 2007 |
| Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease A Latiano, O Palmieri, L Pastorelli, M Vecchi, TT Pizarro, F Bossa, G Merla, ... PloS one 8 (4), e62144, 2013 | 114 | 2013 |
| Plasma N-glycan signatures are associated with features of inflammatory bowel diseases F Clerc, M Novokmet, V Dotz, KR Reiding, N de Haan, GSM Kammeijer, ... Gastroenterology 155 (3), 829-843, 2018 | 113 | 2018 |
| Polymorphisms of tumor necrosis factor-α but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease S Cucchiara, A Latiano, O Palmieri, RB Canani, R D'Incà, G Guariso, ... Journal of pediatric gastroenterology and nutrition 44 (2), 171-179, 2007 | 105 | 2007 |
| Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study A Orlando, E Colombo, A Kohn, L Biancone, F Rizzello, A Viscido, ... Digestive and liver disease 37 (8), 577-583, 2005 | 103 | 2005 |
| Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis P Invernizzi, M Ransom, S Raychaudhuri, R Kosoy, A Lleo, R Shigeta, ... Genes & Immunity 13 (6), 461-468, 2012 | 101 | 2012 |
Angelo AndriulliCasa Sollievo Sofferenzaยืนยันอีเมลแล้วที่ operapadrepio.it
